Skip to content

Medvoxel Systems, Inc.

CanadaFDA applicant, unverified

Devices
1

What Medvoxel Systems, Inc. makes

Medvoxel Systems, Inc. develops the HeartPro software application, a digital tool designed for cardiac imaging analysis and diagnostic support.

The company’s portfolio is regulated under FDA Class II devices and is listed via 510(k) clearance. Medvoxel Systems, Inc. is based in the United States.

AI-generated from registry data, 1 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

Frequently asked questions

How many devices does Medvoxel Systems, Inc. have in the registry?

The registry currently lists 1 device for Medvoxel Systems, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Medvoxel Systems, Inc.'s devices?

Among its 1 most recently registered device, Medvoxel Systems, Inc. has devices listed in FDA 510(k) (1 device).

What risk classes do Medvoxel Systems, Inc.'s devices fall under?

Among its 1 most recently registered device, the classes recorded for Medvoxel Systems, Inc.'s devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Medvoxel Systems, Inc. in the registry?

The most recently registered devices listed for Medvoxel Systems, Inc. include MEDVOXEL HEARTPRO SOFTWARE APPLICATION.

Generated automatically from registry data and not verified by a human reviewer.